T5O — bioXXmed AG Cashflow Statement
0.000.00%
Last trade - 00:00
- €1.55m
- €0.47m
- €0.01m
- 28
- 29
- 14
- 12
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | — | — |
Source: | ARS | ARS | ARS | ||
Standards: | — | — | — | — | — |
Status: | Final | Final | Final | fx Preliminary | fx Preliminary |
Net Income/Starting Line | -1.42 | -1.27 | -1.84 | — | — |
Depreciation | |||||
Non-Cash Items | 0.2 | 0.1 | 0.207 | — | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.07 | 0.245 | -0.047 | — | — |
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -1.26 | -0.911 | -1.66 | — | — |
Capital Expenditures | -0.01 | -0.014 | -0.003 | — | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -3.29 | -2.41 | -4.8 | — | — |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -3.3 | -2.42 | -4.8 | — | — |
Financing Cash Flow Items | -0.199 | -0.015 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.18 | 2.66 | 6.02 | — | — |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.627 | -0.678 | -0.44 | — | — |